NY State Senate Bill S5940

Archive: Last Bill Status - Signed by Governor

Introduced
In Committee
On Floor Calendar
- Passed Senate
- Passed Assembly
Delivered to Governor
Signed by Governor

Your Voice

Please enter your contact information

First Name *

Last Name *

Email Address *

A valid email address is required.

Home address search or enter your address manually *

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Leave this field blank

Actions

view actions (22)

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Dec 21, 2018	signed chap.428
Dec 12, 2018	delivered to governor
Jun 20, 2018	returned to senate passed assembly ordered to third reading rules cal.446 substituted for a8383
Jun 07, 2018	referred to health delivered to assembly passed senate
Jun 05, 2018	advanced to third reading
Jun 04, 2018	2nd report cal.
May 31, 2018	1st report cal.1495
Jan 03, 2018	referred to health returned to senate died in assembly
Jun 13, 2017	referred to health delivered to assembly passed senate
Jun 05, 2017	advanced to third reading
May 24, 2017	2nd report cal.
May 23, 2017	1st report cal.1155
May 08, 2017	referred to health

Votes

Co-Sponsors

S5940 (ACTIVE) - Details

See Assembly Version of this Bill:: A8383
Law Section:: Public Health Law
Laws Affected:: Amd §3306, Pub Health L

S5940 (ACTIVE) - Summary

Relates to substances containing chorionic gonadotropin expressly intended for administration through implants or injection to cattle or other nonhuman species.

S5940 (ACTIVE) - Sponsor Memo

 BILL NUMBER:  S5940

 TITLE OF BILL :

An act to amend the public health law, in relation to substances
containing chorionic gonadotropin

 PURPOSE OR GENERAL IDEA OF BILL :

To relieve veterinarians from the unnecessary burden associated with
complying with controlled substance requirements for the use
veterinary use of hCG. This bill mirrors current language that exempts
formulations for animals containing anabolic steroids under
subdivision (i) of schedule II of section 3306 of the public health
law.

 SUMMARY OF SPECIFIC PROVISIONS :

Section 1 amends Schedule III of section 3306 of the public health law
to exempt substances containing human chorionic gonadotropin (hCG)
that are expressly intended for use in animals from the provisions of
the controlled substances law.

Section 2 takes effect in 180 days after it is signed in to law.

 JUSTIFICATION :

Human Chorionic Gonadotropin (hCG) is safe and effective when
formulated for treating specific reproductive conditions in cattle and
fish. This bill will allow veterinarians to have improved access to
use such formulations to ensure that animals remain healthy and
productive. The language in the bill mirrors the existing exemption
for products formulated for animals containing anabolic steroids.
hCG, has been used by athletes and body builders as an agent to
improve testosterone production and counteract the negative side
effects due to use of anabolic steroids. As a consequence, a number of
states, including NY, included hCG on their schedule of controlled
substances.

However, most states, 44, have exempted hCG containing products
formulated for use in animals. In fact, US Drug Enforcement Agency
does not classify such formulations as controlled substances, meaning
it can be sold as a veterinary product without the additional
documentation or security requirements associated with controlled
substances

This bill does not lesson the penalties for the prescription,
distribution or diversion of the hCG containing products for use in
humans. It simply seeks to relieve distributors, farmers, and
veterinarians from the cost and difficulty associated with handling a
product listed under Schedule III.

 PRIOR LEGISLATIVE HISTORY :

This is a new bill.

 FISCAL IMPLICATIONS :

None

 EFFECTIVE DATE :
180 days after is shall have become law.

S5940 (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  5940

                       2017-2018 Regular Sessions

                            I N  S E N A T E

                               May 8, 2017
                               ___________

Introduced  by  Sen. VALESKY -- read twice and ordered printed, and when
  printed to be committed to the Committee on Health

AN ACT to amend  the  public  health  law,  in  relation  to  substances
  containing chorionic gonadotropin

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. Subdivision (g) of schedule III  of  section  3306  of  the
public  health  law,  as  amended by chapter 457 of the laws of 2006, is
amended to read as follow:
  (g) Chorionic gonadotropin. (1) Unless specifically excepted or unless
listed in another schedule any material, compound, mixture, or  prepara-
tion which contains any amount of chorionic gonadotropin.
  (2)  PARAGRAPH ONE OF THIS SUBDIVISION SHALL NOT INCLUDE ANY SUBSTANCE
CONTAINING CHORIONIC GONADOTROPIN EXPRESSLY INTENDED FOR  ADMINISTRATION
THROUGH  IMPLANTS  OR  INJECTION TO CATTLE OR OTHER NONHUMAN SPECIES AND
THAT ARE APPROVED BY THE FEDERAL FOOD AND DRUG ADMINISTRATION SOLELY FOR
SUCH USE. ANY INDIVIDUAL WHO  KNOWINGLY  AND  WILLFULLY  ADMINISTERS  TO
HIMSELF  OR  ANOTHER  PERSON,  PRESCRIBES, DISPENSES OR DISTRIBUTES SUCH
SUBSTANCES FOR OTHER THAN IMPLANTATION OR INJECTION TO CATTLE OR  NONHU-
MAN SPECIES SHALL BE SUBJECT TO THE SAME PENALTIES AS A PRACTITIONER WHO
VIOLATES   THE  PROVISIONS  OF  THIS  SECTION  OR  ANY  OTHER  PENALTIES
PRESCRIBED BY LAW.
  § 2. This act shall take effect on the one hundred eightieth day after
it shall have become a law.



 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD11462-01-7

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.

The New York State Senate

senate Bill S5940

Sponsored By

Archive: Last Bill Status - Signed by Governor

Your Voice

Actions

Votes

Jun 7, 2018 - floor Vote

Floor Vote: Jun 7, 2018

May 31, 2018 - Health committee Vote

Health Committee Vote: May 31, 2018

Jun 13, 2017 - floor Vote

Floor Vote: Jun 13, 2017

May 23, 2017 - Health committee Vote

Health Committee Vote: May 23, 2017

Co-Sponsors

S5940 (ACTIVE) - Details

S5940 (ACTIVE) - Summary

S5940 (ACTIVE) - Sponsor Memo

S5940 (ACTIVE) - Bill Text download pdf

Comments

senate Bill S5940

Share this bill

Sponsored By

David J. Valesky

Archive: Last Bill Status - Signed by Governor

Your Voice

Actions

Votes

Jun 7, 2018 - floor Vote

Floor Vote: Jun 7, 2018

May 31, 2018 - Health committee Vote

Health Committee Vote: May 31, 2018

Jun 13, 2017 - floor Vote

Floor Vote: Jun 13, 2017

May 23, 2017 - Health committee Vote

Health Committee Vote: May 23, 2017

Co-Sponsors

Patty Ritchie

S5940 (ACTIVE) - Details

S5940 (ACTIVE) - Summary

S5940 (ACTIVE) - Sponsor Memo

S5940 (ACTIVE) - Bill Text download pdf

Comments